Hashem Yaghoubi

Hashem Yaghoubi

Auto-generated profile, based on publicly available information

Hashem Yaghoubi

Department of Biology, Ard.C., Islamic Azad University, Ardabil, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2024 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
SBShima Bourang
Shima Bourang
MNMehran Noruzpour
Mehran Noruzpour
SGSodabeh Jahanbakhsh Godekahriz
Sodabeh Jahanbakhsh Godekahriz
HEHossein Ali Ebrahimi
Hossein Ali Ebrahimi
SJSoodabeh Jahanbakhsh
Soodabeh Jahanbakhsh
HYHashem Yaghoubi
Hashem Yaghoubi

29 January 2024 in Medicine in Drug Discovery
Verified
Journal Article
Open access
FAFarnaz Ahmadi-Nouraldinvand
Farnaz Ahmadi-Nouraldinvand
SBShima Bourang
Shima Bourang
SASolmaz Azizi
Solmaz Azizi
MNMohsen Noori
Mohsen Noori
MNMehran Noruzpour
Mehran Noruzpour
HYHashem Yaghoubi
Hashem Yaghoubi

20 July 2026 in Medical Journal of Tabriz University of Medical Sciences
Verified
Journal Article
Open access
PDF file
HYHashem Yaghoubi
Hashem Yaghoubi
MNMehran Noruzpour
Mehran Noruzpour
Background. Nanotechnology addresses the challenge of targeted drug and nucleic acid delivery to cancer cells through the design of intelligent carriers. This study was conducted to design a smart nanocarrier based on PCL/Chitosan/PEG functionalized with hyaluronic acid (HA) for the delivery of siRNA to breast cancer cells (MCF-7). Methods. The physicochemical properties of the synthesized nanoparticles were analyzed using 1H-NMR and TGA. Zeta potential and nanoparticle size were assessed using dynamic light scattering (DLS), confirming successful synthesis. Results. DLS analysis revealed that after loading siRNA-FAM, the size of PCPH nanoparticles increased from 201±7 nm to 294±9 nm, and that of PEI nanoparticles from 186±11 nm to 220±6 nm. Meanwhile, siRNA loading reduced the zeta potential of PCPH nanoparticles from +1.72±0.52 mV to -2.5±0.50 mV. The results showed that at neutral pH, PEI/siRNA-FAM exhibited significantly higher release than PCPH after 480 minutes, whereas in an acidic environment, both nanoparticles released siRNA-FAM at a similar rate. Cytotoxicity assessment indicated that PCPH nanoparticles carrying siRNA had significant inhibitory effects on the growth of MCF-7 cells. The results of gel electrophoresis confirmed that PCPH nanoparticles effectively interacted electrostatically with siRNA-FAM, neutralizing its negative charge and halting its migration in the gel. Conclusion. PCL-Chitosan-PEG-HA nanoparticles serve as a biocompatible and targeted system for siRNA delivery to cancer cells, demonstrating high efficiency in targeted gene therapy. Practical Implications. The findings of this study represent a significant step toward more personalized and effective cancer treatments using nanotechnology.